On June 27, 2026, Cuu Long Pharmaceutical Joint Stock Company (DCL) was honored among the Top 10 Leading Famous Brands 2026. The award was presented under a program jointly organized by the Institute of Development Issues, the Institute of Economics and Culture, and the Vietnam Consumer Protection Center, recognizing enterprises that have made significant contributions to manufacturing, business development, brand building, and improving the quality of products and services.
The program aims to recognize and honor entrepreneurs, intellectuals, and businesses that have made outstanding contributions to socio-economic development, innovation, digital transformation, and the promotion of Vietnamese brands. It also encourages the growth of domestic production, supports the development of strong Vietnamese brands and products, and protects the legitimate rights and interests of consumers.
The Top 10 Leading Famous Brands 2026 title recognizes DCL’s persistent efforts throughout its 50-year journey of continuous innovation, manufacturing excellence, and commitment to providing high-quality pharmaceutical products that meet the healthcare needs of people in Vietnam while gradually expanding into international markets.
Ms. Nguyen Thi Thu Huong, CEO of DCL, receives the Top 10 Leading Famous Brands 2026 award.
As one of Vietnam’s leading pharmaceutical companies, DCL has remained committed to a development strategy built on quality, innovation, and sustainable growth. The company continues to invest in upgrading its manufacturing facilities and production lines to international standards while strengthening research and product development to enhance value and competitiveness.
In addition to product development, DCL continuously improves its corporate governance system, optimizes manufacturing operations, and invests in workforce development. The company believes that its people are the foundation of every success, as the dedication, expertise, and commitment of its employees have been instrumental in building the sustainable value of the DCL brand.
Speaking at the award ceremony, Ms. Nguyen Thi Thu Huong, Chief Executive Officer of Cuu Long Pharmaceutical Joint Stock Company, shared: “Being recognized among the Top 10 Leading Famous Brands 2026 is both a great honor and a strong motivation for DCL to continue striving for excellence. We believe that the true value of a brand is built not only on product quality but also on the trust of our customers and partners, as well as our meaningful contributions to the community. DCL will continue investing in technology, developing high-quality talent, and delivering safe and effective pharmaceutical products while continuously innovating to create greater value for Vietnam’s pharmaceutical industry.”
As Vietnam’s pharmaceutical sector faces both new opportunities and challenges, DCL remains committed to technological innovation, enhancing manufacturing capabilities in line with international standards, and pursuing sustainable development as key strategic priorities. The company also continues to invest in research, expand its product portfolio, and strengthen operational excellence to meet the evolving demands of the market.
This recognition is not only an acknowledgment of DCL’s achievements but also a source of motivation for the company to remain steadfast in its mission of improving community health through high-quality pharmaceutical products. Backed by 50 years of development and a long-term investment strategy, DCL will continue strengthening its position as a trusted Vietnamese pharmaceutical company while contributing to the advancement of Vietnam’s pharmaceutical industry both domestically and internationally.
